Author

Jeyaluxmy Sivalingam

Louisiana State University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Lin LiiD· 3 shared Xiuping YuiD· 3 shared Michael S. LaniD· 2 shared SIYUAN CHENGiD· 2 shared Yingli ShiiD· 2 shared Chiachen CheniD· 1 shared Elahe MahdavianiD· 1 shared Kaleigh Ballagh· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Lin LiORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 31, 2026

INSM1 Regulates Neuroendocrine Plasticity and Tumor Progression in Prostate Cancer

Chiachen Chen, SIYUAN CHENG, Lin Li…·Michael S. Lan

This study identifies INSM1 as a key regulator of neuroendocrine plasticity and tumor progression in prostate cancer, showing its role in lineage programs and identifying HHT as a potential therapeutic agent.

DOI 10.64898/2026.07.30.741780

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyNeoplasiaPeer-reviewedApr 17, 2026

A MYC Family Switch: L-MYC Drives and Maintains Neuroendocrine Lineage Programs in Prostate Cancer

Jeyaluxmy Sivalingam, Kaleigh Ballagh, Kyung Hyun Cho…·Xiuping Yu

This study identifies MYCL as a key driver of neuroendocrine lineage programs in prostate cancer by showing its upregulation in NEPC and its role in suppressing AR signaling and inducing neuroendocrine reprogramming.

DOI 10.1016/j.neo.2026.101307

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMar 25, 2025

Wnt/Beta-Catenin Signaling Is Active in Neuroendocrine Prostate Cancer

Yingli Shi, Shu Yang, Lin Li…·Xiuping Yu

This study investigates Wnt/beta-Catenin signaling in neuroendocrine prostate cancer, finding elevated pathway activity and potential therapeutic targeting.

DOI 10.1101/2025.03.25.645248

mousebulk RNA-seq

𝕏 PostBluesky